DRUG firm Glenmark Pharmaceuticals on Monday said it has achieved positive results in human trials for its new drug molecule Crofelemer, which is aimed at treating diarrhoea in adults.

In a filing to the Bombay Stock Exchange (BSE), the firm said resolution of diarrhoea was significantly higher in human subjects, who were given Crofelemer compared to those who were not in a multi-centre tri